Why the Accent (ASX:AX1) share price is sinking 6% today

Accent shares are closing in on a 52-week low…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Accent Group Ltd (ASX: AX1) share price is having a tough start to the week.

In afternoon trade, the footwear focused retailer's shares are down 6% to $2.19.

This leaves the Accent share price trading within sight of its 52-week low of $2.03.

A woman sits on her lounge looking stressed and surprised while reading news on her phone.

Image source: Getty Images

Why is the Accent share price falling?

The weakness in the Accent share price today appears to have been driven by a broker note out of Morgans this morning.

According to the note, the broker has retained its hold rating but trimmed its price target on the company's shares by 6.5% to $2.40.

Morgans made the move after changing its analyst and adjusting its estimates.

What did the broker say?

The note reveals that Morgans has reduced its earnings before interest and tax (EBIT) estimate for FY 2022.

It now expects EBIT of $97.4 million for the full year, down from $102.1 million previously. This is notably lower than the current consensus estimate of $103.4 million and will be a sizeable decline from FY 2021's EBIT of $124.9 million.

Most of the damage to its profits is expected in the first half of FY 2022 following lockdowns.

Morgans explained: "We forecast a 53.3% drop in first half EBIT to $38.2m, with the decline mainly a function of the impact of lockdowns and the non-recurrence of the $9m JobKeeper benefit received in the PCP. Our estimate is 19% lower than Visible Alpha consensus ($47.4m with a broad range of $36.5-58.5m)."

Combined with its current valuation, the broker doesn't appear to believe enough value for money is on offer with the Accent share price at this point.

The broker concludes: "AX1 has a multi-faceted growth strategy, but this is countered by a 23x FY22F P/E ratio, higher gearing than many of its peers, and the reliance on distribution agreements with large third-party suppliers. We rate the stock a HOLD."

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Accent Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Morgans names 2 ASX shares to buy and 1 to accumulate

What is the broker recommending investors do with these shares?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

2 ASX 200 shares to buy ahead of anticipated rally: expert

After a 9.1% drop between 27 February and 23 March, the ASX 200 reversed course last Tuesday.

Read more »

A group of people in a corporate setting do a collective high five.
Broker Notes

3 reasons to buy Ramsay Health Care shares today

A leading analyst expects Ramsay Health Care shares to keep outperforming in the months ahead.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Broker Notes

Bell Potter says this ASX 200 stock can rise 38% and pay a 6% dividend yield

Major upside and a generous dividend yield could be on offer with this name.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Is this ASX defence stock the next DroneShield?

Bell Potter thinks this stock could be the next to rocket. Let's find out why.

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Broker Notes

This ASX healthcare stock could almost double in value according to Bell Potter

The broker believes this stock is making major breakthroughs.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

a miner holds his thumb up as he holds a device in his other hand.
Resources Shares

Experts name 3 ASX mining shares to buy after March sell-off

Investors took profits amid fears the fuel crisis could impact miners' production and earnings.

Read more »